Clinical Research Coordinator 2
Iterative Health
Clinical Research Coordinator 2
Iterative Health
AI-powered polyp detection for colorectal cancer
Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes.
We built a leading performance-driven network of 100+ sites across the US, Europe, India, and Australia, conducting research directly in the communities where care is delivered across gastrointestinal, hepatology, obesity, and cardiology. By combining deep clinical trial expertise with cutting-edge AI, we connect sponsors' scientific ambitions with high-performing research teams that expedite and expand access to novel therapeutics for patients in need. Today, Iterative Health is headquartered in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.
As a Clinical Research Coordinator II (CRC II) at Iterative Health you will play a critical role in the successful execution of clinical trials by independently coordinating daily study activities and ensuring compliance with protocol requirements, regulatory standards, and patient safety guidelines.
This role is responsible for managing complex studies with minimal oversight while partnering closely with patients, investigators, sponsors, CROs, and internal teams to drive high-quality study execution and enrollment success.
What You Bring to the Team
At Iterative Health, we’re actively working towards creating an environment that is representative of the diversity of patients our technology serves. We are focused on building an equitable and inclusive culture, and by extension, hiring process. If you require any accommodations to make the application process or interviewing experience more accessible to you, please contact [email protected].
AI-powered polyp detection for colorectal cancer
Iterative Health develops and deploys AI-powered tools for gastrointestinal (GI) care. Its main product is SKOUT®, an FDA-cleared device that helps doctors find adenomas (polyps) during GI procedures, supporting clinical judgment rather than replacing it. The company also offers AI-enabled documentation and data standardization technologies to improve the quality of patient care and to streamline clinical trials, enabling consistent reporting across institutions. By combining AI image analysis, data-driven insights, and streamlined research workflows, Iterative Health aims to improve colorectal cancer prevention and diagnosis and to extend high-quality GI care to underserved populations around the world.
Explore more opportunities at Iterative Health